The Zacks Analyst Blog The Goldman Sachs, JP Morgan, Barclays and Morgan Stanley

In This Article:

For Immediate Releases

Chicago, IL – January 22, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include, The Goldman Sachs Group, Inc. GS, JP Morgan JPM, Barclays BCS and Morgan Stanley MS.

Here are highlights from Wednesday’s Analyst Blog:

Goldman Sachs Hits All-Time High: Room to Run or Time to Sell?

The Goldman Sachs Group, Inc. shares touched an all-time high of $627 during Friday’s trading session before closing the session slightly lower at $625.94.

Over the past year, the stock has soared 66.1% compared with the industry’s growth of 56% and the S&P 500 index rise of 26.4%. GS peers JP Morgan and Morgan Stanley have gained 66.7% and 55.8%, respectively, during the same time frame.

Price Performance

The primary reason for investors’ optimistic stance on Goldman is the impressive fourth-quarter 2024 results (released on Jan.15, 2025). The company registered solid top and bottom-line growth in the reported quarter. Its investment banking (IB) income increased 24% year over year. Driven by a robust performance, the company’s profits jumped 37.5%.

Along with strong quarterly results, the expectations of increased merger and acquisition (M&A) momentum, driven by potential easing regulatory oversight under the Trump administration, will likely support Goldman’s IB business.

Let us delve deeper and analyze other factors to find out whether now is the right time to buy the GS stock or wait for a better entry point.

Global Deal-Making Revival & Less Regulation: The IB industry thrived in 2024, following a rebound in corporate debt, equity issuances and deal-making activities. This supported growth in IB fees.

The macroeconomic environment is steadying, driven by the interest rate-cut cycle globally and robust U.S. economic growth. With this, underwriting and M&A activities are on the path to a sustained recovery in the coming days. Also, the Donald Trump administration is likely to be friendlier toward corporate mergers as the easing of some rules for big banks and more leniency in approving merger deals are expected. This will likely support Goldman’s IB performance.

In 2022 and 2023, GS’s IB revenues declined 47.9% and 15.5% year over year, respectively. However, a substantial improvement in the industry-wide deal value and volume in 2024 drove global M&As. Hence, the company’s IB revenues jumped 24% to $7.73 billion from 2023.